Skip to main content
Erschienen in: Pediatric Cardiology 7/2016

17.06.2016 | Original Article

Cardiac Disease Burden and Risk of Mortality in Hospitalized Muscular Dystrophy Patients

verfasst von: Ann R. Punnoose, Jonathan R. Kaltman, William Pastor, Robert McCarter, Jianping He, Christopher F. Spurney

Erschienen in: Pediatric Cardiology | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

As treatments of the extra-cardiac complications of muscular dystrophy (MD) improve, males with MD are more likely to develop cardiac disease. The impact of cardiomyopathy or heart failure (HF) and ventricular tachycardia (VT) on hospitalizations and in hospital mortality are not known. We performed an analysis of inpatient admission data for patients with MD using the Pediatric Health Information System database. We selected males who were 6 years or older with diagnosis codes of MD and cardiac disease including cardiomyopathy/HF and VT between 2003 and 2013. We created a logistic regression model to identify predictors of subsequent cardiac arrest or death in MD patients. We also compared hospital charges, lengths of stay and ages among MD patients with or without cardiac disease. Our logistic regression model showed that VT (OR 5.41, 95 % CI 2.83, 10.34) and cardiomyopathy/HF (OR 1.79, 95 % CI 1.05, 3.04) were risk factors for cardiac arrest or death. Of the 84 cardiac arrests or deaths in 3363 MD patients, 49 (58 %) were related to cardiac disease. Nineteen (39 %) of these events occurred in MD patients with VT. The mean hospital charges and the mean length of stay were greater and longer in MD patients with VT compared to those without cardiac disease and those with only cardiomyopathy/HF (p < 0.05). Cardiac disease is a significant burden in hospitalized MD patients. Our results suggest that VT and cardiomyopathy/HF are associated with an increased risk of cardiac arrest or death in MD patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Mercuri E, Muntoni F (2013) Muscular dystrophy: new challenges and review of the current clinical trials. Curr Opin Pediatr 25:701–707CrossRefPubMed Mercuri E, Muntoni F (2013) Muscular dystrophy: new challenges and review of the current clinical trials. Curr Opin Pediatr 25:701–707CrossRefPubMed
2.
Zurück zum Zitat Sarnat HB (2007) Neuromuscular Disorders. In: Kleigman RM, Behrman RE, Jenson HB, Stanton BF (eds) Nelson textbook of pediatrics, 18th edn. Saunders Elsevier, Philadelphia, pp 2531–2568 Sarnat HB (2007) Neuromuscular Disorders. In: Kleigman RM, Behrman RE, Jenson HB, Stanton BF (eds) Nelson textbook of pediatrics, 18th edn. Saunders Elsevier, Philadelphia, pp 2531–2568
3.
Zurück zum Zitat Theadom A, Rodriguez M, Roxburgh R, Balalla S, Higgins C, Bhattacharjee R, Jones K, Krishnamurthi R, Feigin V (2014) Prevalence of muscular dystrophies: a systematic literature review. Neuroepidemiology 43:259–268CrossRefPubMed Theadom A, Rodriguez M, Roxburgh R, Balalla S, Higgins C, Bhattacharjee R, Jones K, Krishnamurthi R, Feigin V (2014) Prevalence of muscular dystrophies: a systematic literature review. Neuroepidemiology 43:259–268CrossRefPubMed
4.
Zurück zum Zitat Emery AE (1991) Population frequencies of inherited neuromuscular diseases—a world survey. Neuromuscul Disord 1:19–29CrossRefPubMed Emery AE (1991) Population frequencies of inherited neuromuscular diseases—a world survey. Neuromuscul Disord 1:19–29CrossRefPubMed
5.
Zurück zum Zitat Mendell JR, Shilling C, Leslie ND, Flanigan KM, al-Dahhak R, Gastier-Foster J, Kneile K, Dunn DM, Duval B, Aoyagi A, Hamil C, Mahmoud M, Roush K, Bird L, Rankin C, Lilly H, Street N, Chandrasekar R, Weiss RB (2012) Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol 71:304–313CrossRefPubMed Mendell JR, Shilling C, Leslie ND, Flanigan KM, al-Dahhak R, Gastier-Foster J, Kneile K, Dunn DM, Duval B, Aoyagi A, Hamil C, Mahmoud M, Roush K, Bird L, Rankin C, Lilly H, Street N, Chandrasekar R, Weiss RB (2012) Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol 71:304–313CrossRefPubMed
6.
Zurück zum Zitat Spurney CF (2011) Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions. Muscle Nerve 44:8–19CrossRefPubMed Spurney CF (2011) Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions. Muscle Nerve 44:8–19CrossRefPubMed
7.
Zurück zum Zitat Fauconnier J, Thireau J, Reiken S, Cassan C, Richard S, Matecki S, Marks AR, Lacampagne A (2010) Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy. PNAS 107:1559–1564CrossRefPubMedPubMedCentral Fauconnier J, Thireau J, Reiken S, Cassan C, Richard S, Matecki S, Marks AR, Lacampagne A (2010) Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy. PNAS 107:1559–1564CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Finder JD, Birnkrant D, Carl J, Farber HJ, Gozal D, Iannaccone ST, Kovesi T, Kravitz RM, Panitch H, Schramm C, Schroth M, Sharma G, Sievers L, Silvestri JM, Sterni L, American Thoracic Society (2004) Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med 170:456–465CrossRefPubMed Finder JD, Birnkrant D, Carl J, Farber HJ, Gozal D, Iannaccone ST, Kovesi T, Kravitz RM, Panitch H, Schramm C, Schroth M, Sharma G, Sievers L, Silvestri JM, Sterni L, American Thoracic Society (2004) Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med 170:456–465CrossRefPubMed
9.
Zurück zum Zitat Moxley RT, Pandya S, Ciafaloni E, Fox DJ, Campbell K (2010) Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management. J Child Neurol 9:1116–1129CrossRef Moxley RT, Pandya S, Ciafaloni E, Fox DJ, Campbell K (2010) Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management. J Child Neurol 9:1116–1129CrossRef
10.
Zurück zum Zitat Eagle M, Baudoin SV, Chandler C, Giddings D, Bullock R, Bushby K (2002) Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 12:926–929CrossRefPubMed Eagle M, Baudoin SV, Chandler C, Giddings D, Bullock R, Bushby K (2002) Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 12:926–929CrossRefPubMed
11.
Zurück zum Zitat Spurney C, Shimizu R, Morgenroth LP, Kolski H, Gordish-Dressman H, Clemens PR, CINRG Investigators et al (2014) Cooperative International Neuromuscular Research Group Duchenne Natural History Study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy. Muscle Nerve 50:250–256CrossRefPubMedPubMedCentral Spurney C, Shimizu R, Morgenroth LP, Kolski H, Gordish-Dressman H, Clemens PR, CINRG Investigators et al (2014) Cooperative International Neuromuscular Research Group Duchenne Natural History Study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy. Muscle Nerve 50:250–256CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Barber BJ, Andrews JG, Lu Z, West N, Meaney FJ, Price ET, Gray A, Sheehan DW, Pandya S, Yang M, Cunniff C (2013) Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy. J Pediatr 163:1080–1084CrossRefPubMed Barber BJ, Andrews JG, Lu Z, West N, Meaney FJ, Price ET, Gray A, Sheehan DW, Pandya S, Yang M, Cunniff C (2013) Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy. J Pediatr 163:1080–1084CrossRefPubMed
13.
Zurück zum Zitat Finsterer J, Stollberger C (2003) The heart in human dystrophinopathies. Cardiology 99:1–19CrossRefPubMed Finsterer J, Stollberger C (2003) The heart in human dystrophinopathies. Cardiology 99:1–19CrossRefPubMed
14.
Zurück zum Zitat Nigro G, Comi LI, Politano L, Bain RJ (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26:271–277CrossRefPubMed Nigro G, Comi LI, Politano L, Bain RJ (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26:271–277CrossRefPubMed
15.
Zurück zum Zitat Connuck DM, Sleeper LA, Colan SD, Cox GF, Towbin JA, Lowe AM, Wilkinson JD, Orav EJ, Cuniberti L, Salbert BA, Lipshultz SE, Pediatric Cardiomyopathy Registry Study Group (2008) Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the pediatric cardiomyopathy registry. Am Heart J 155:998–1005CrossRefPubMedPubMedCentral Connuck DM, Sleeper LA, Colan SD, Cox GF, Towbin JA, Lowe AM, Wilkinson JD, Orav EJ, Cuniberti L, Salbert BA, Lipshultz SE, Pediatric Cardiomyopathy Registry Study Group (2008) Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the pediatric cardiomyopathy registry. Am Heart J 155:998–1005CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Duboc D, Meune C, Pierre B, Wahbi K, Eymard B, Toutain A, Berard C, Vaksmann G, Weber S, Becane HM (2007) Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years’ follow-up. Am Heart J 154:595–602CrossRef Duboc D, Meune C, Pierre B, Wahbi K, Eymard B, Toutain A, Berard C, Vaksmann G, Weber S, Becane HM (2007) Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years’ follow-up. Am Heart J 154:595–602CrossRef
17.
Zurück zum Zitat Wagner KR, Lechtzin N, Judge DP (2007) Current treatment of adult Duchenne muscular dystrophy. Biochim Biophys Acta 1772:229–237CrossRefPubMed Wagner KR, Lechtzin N, Judge DP (2007) Current treatment of adult Duchenne muscular dystrophy. Biochim Biophys Acta 1772:229–237CrossRefPubMed
18.
Zurück zum Zitat Yanagisawa A, Miyagawa M, Yotsukura M, Tsuya T, Shirato C, Ishihara T, Aoyagi T, Ishikawa K (1992) The prevalence and prognostic significance of arrhythmias in Duchenne type muscular dystrophy. Am Heart J 124:1244–1250CrossRefPubMed Yanagisawa A, Miyagawa M, Yotsukura M, Tsuya T, Shirato C, Ishihara T, Aoyagi T, Ishikawa K (1992) The prevalence and prognostic significance of arrhythmias in Duchenne type muscular dystrophy. Am Heart J 124:1244–1250CrossRefPubMed
19.
Zurück zum Zitat Chenard AA, Becane HM, Tertrain F, de Kermadec JM, Weiss YA (1993) Ventricular arrhythmia in Duchenne muscular dystrophy: prevalence, significance and prognosis. Neuromuscul Disord 3:201–206CrossRefPubMed Chenard AA, Becane HM, Tertrain F, de Kermadec JM, Weiss YA (1993) Ventricular arrhythmia in Duchenne muscular dystrophy: prevalence, significance and prognosis. Neuromuscul Disord 3:201–206CrossRefPubMed
20.
Zurück zum Zitat Groh WJ (1985) Arrhythmias in the muscular dystrophies. Heart Rhythm 9:1890–1895CrossRef Groh WJ (1985) Arrhythmias in the muscular dystrophies. Heart Rhythm 9:1890–1895CrossRef
21.
Zurück zum Zitat Diegoli M, Grasso M, Favalli V, Seria A, Gambarin FI, Klersy C, Pasott M, Agozzino E, Scelsi L, Ferlini A, Febo O, Piccoli G, Tavazzi L, Narula J, Arbustini E (2011) Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects. J Am Coll Cardiol 58:925–934CrossRefPubMed Diegoli M, Grasso M, Favalli V, Seria A, Gambarin FI, Klersy C, Pasott M, Agozzino E, Scelsi L, Ferlini A, Febo O, Piccoli G, Tavazzi L, Narula J, Arbustini E (2011) Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects. J Am Coll Cardiol 58:925–934CrossRefPubMed
23.
Zurück zum Zitat Gulati S, Saxena A, Kumar V, Kalra V (2005) Duchenne muscular dystrophy: prevalence and patterns of cardiac involvement. Indian J Pediatr 72:389–393CrossRefPubMed Gulati S, Saxena A, Kumar V, Kalra V (2005) Duchenne muscular dystrophy: prevalence and patterns of cardiac involvement. Indian J Pediatr 72:389–393CrossRefPubMed
24.
Zurück zum Zitat Corrado G, Lissoni A, Beretta S, Terenghi L, Tadeo G, Foglia-Manzillo G, Tagliagambe LM, Spata M, Santarone M (2002) Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 89:838–841CrossRefPubMed Corrado G, Lissoni A, Beretta S, Terenghi L, Tadeo G, Foglia-Manzillo G, Tagliagambe LM, Spata M, Santarone M (2002) Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 89:838–841CrossRefPubMed
25.
Zurück zum Zitat Singh SN, Fisher SG, Carson PE, Fletcher RD, The Department of Veteran Affairs CHF-STAT Investigators (1998) Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. J Am Coll Cardiol 32:942–947CrossRefPubMed Singh SN, Fisher SG, Carson PE, Fletcher RD, The Department of Veteran Affairs CHF-STAT Investigators (1998) Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. J Am Coll Cardiol 32:942–947CrossRefPubMed
26.
Zurück zum Zitat Von Olshausen K, Schafer A, Mehmel HC, Schwarz F, Senger J, Kubler W (1984) Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J 51:195–201CrossRef Von Olshausen K, Schafer A, Mehmel HC, Schwarz F, Senger J, Kubler W (1984) Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J 51:195–201CrossRef
27.
Zurück zum Zitat Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemns PA, Cripe L, Kaul A, Kinnett K, McDonal C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C, DMD Care Considerations Working Group (2010) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9:77–93CrossRefPubMed Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemns PA, Cripe L, Kaul A, Kinnett K, McDonal C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C, DMD Care Considerations Working Group (2010) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9:77–93CrossRefPubMed
28.
Zurück zum Zitat Spurney CF (2011) Cardiac complications of neuromuscular disorders. In: Bertorini TE (ed) Neuromuscular diseases: management and therapy, 1st edn. Saunders Elsevier, Philadelphia, pp 33–50 Spurney CF (2011) Cardiac complications of neuromuscular disorders. In: Bertorini TE (ed) Neuromuscular diseases: management and therapy, 1st edn. Saunders Elsevier, Philadelphia, pp 33–50
29.
Zurück zum Zitat Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaecter A, Levine JH, Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators (2004) Prophylactic defibrillators implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350:2151–2158CrossRefPubMed Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaecter A, Levine JH, Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators (2004) Prophylactic defibrillators implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350:2151–2158CrossRefPubMed
30.
Zurück zum Zitat Grimm W, Jurgen Hoffman, Muller HH, Maisch B (2002) Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on holter and a left ventricular ejection fraction below 30 %. J Am Coll Cardiol 39:780–787CrossRefPubMed Grimm W, Jurgen Hoffman, Muller HH, Maisch B (2002) Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on holter and a left ventricular ejection fraction below 30 %. J Am Coll Cardiol 39:780–787CrossRefPubMed
31.
Zurück zum Zitat Moss AJ, Zareba W, Hall J, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, Multicenter Automatic Defibrillator Implantation Trial II Investigators (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883CrossRefPubMed Moss AJ, Zareba W, Hall J, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, Multicenter Automatic Defibrillator Implantation Trial II Investigators (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883CrossRefPubMed
32.
Zurück zum Zitat Bell CF, Kurosky SK, Candrilli SD (2015) Muscular dystrophy-related hospitalizations among male pediatric patients in the United States. Hosp Pract 1995:1–6 Bell CF, Kurosky SK, Candrilli SD (2015) Muscular dystrophy-related hospitalizations among male pediatric patients in the United States. Hosp Pract 1995:1–6
33.
Zurück zum Zitat McNally EM, Kaltman JR, Benson DW, Canter CE, Cripe LH, Duan D, Finder JD, Hoffman EP, Judge DP, Kertesz N, Kinnett K, Kirsch R, Metzger JM, Pearson GD, Rafael-Fortney JA, Raman SV, Spurney CF, Targum SL, Wagner KR, Markham LW (2015) Contemporary cardiac issues in Duchenne muscular dystrophy. Circulation 131:1590–1598CrossRefPubMedPubMedCentral McNally EM, Kaltman JR, Benson DW, Canter CE, Cripe LH, Duan D, Finder JD, Hoffman EP, Judge DP, Kertesz N, Kinnett K, Kirsch R, Metzger JM, Pearson GD, Rafael-Fortney JA, Raman SV, Spurney CF, Targum SL, Wagner KR, Markham LW (2015) Contemporary cardiac issues in Duchenne muscular dystrophy. Circulation 131:1590–1598CrossRefPubMedPubMedCentral
Metadaten
Titel
Cardiac Disease Burden and Risk of Mortality in Hospitalized Muscular Dystrophy Patients
verfasst von
Ann R. Punnoose
Jonathan R. Kaltman
William Pastor
Robert McCarter
Jianping He
Christopher F. Spurney
Publikationsdatum
17.06.2016
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 7/2016
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-016-1432-5

Weitere Artikel der Ausgabe 7/2016

Pediatric Cardiology 7/2016 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.